-
Barinthus Biotherapeutics plc (formerly
Vaccitech plc) is a
biotechnology company developing immunotherapies for
infectious diseases,
cancer and autoimmune...
-
vaccines and
immune responses,
retrieved 17
February 2018 "Our Team -
Vaccitech".
vaccitech.co.uk.
Retrieved 17
February 2018. "Dramatic
increase in the UK...
-
Professor of
Vaccinology at the
University of
Oxford and co-founder of
Vaccitech. She
specialises in the
development of
vaccines against influenza and...
-
character in the "Merry Gentry"
series of
books by
Laurell K.
Hamilton Vaccitech, a
biotech company that
renamed to
Barinthus Biotherapeutics in 2023 This...
- FDA
authorized emergency use only. AstraZeneca–University of
Oxford and
Vaccitech Modified chimpanzee adenovirus viral vector $1.2Â billion May 21, 2020...
-
Street Journal.
Retrieved 15 July 2021. "Scientific
Advisory Board".
Vaccitech.
Retrieved 15 July 2021. "Jerome Kim
Named to Head
South Korea's International...
-
Covishield is
developed by the
University of
Oxford and its spin-out company,
Vaccitech. On 2
January 2021,
Covaxin India's
first COVID-19 vaccine, developed...
- from a
collaboration between Oxford University's
Jenner Institute and
Vaccitech, a
private company spun off from the university, with
financing from Oxford...
-
vaccine being developed by
AstraZeneca and the
University of Oxford's
Vaccitech. SII
joined GAVI in a
partnership with the Bill &
Melinda Gates Foundation...
-
Covishield is
developed by the
University of
Oxford and its spin-out company,
Vaccitech. It's a
viral vector vaccine based on replication-deficient Adenovirus...
